| Literature DB >> 32104975 |
Dennis Kubiczek1, Carolin Flaig1, Heinz Raber1, Steffen Dietz1, Ann-Kathrin Kissmann1, Thomas Heerde1, Nicholas Bodenberger2, Andreas Wittgens2, Melaine González-Garcia3, Fan Kang4, Octavio L Franco5,6, Ludger Staendker7, Anselmo J Otero-González3, Paul Walther8, Kay E Gottschalk4, Tanja Weil2, Frank Rosenau1,2.
Abstract
The pathogenic yeast Candida auris has received increasing attention due to its ability to cause fatal infections, its resistance toward important fungicides, and its ability to persist on surfaces including medical devices in hospitals. To brace health care systems for this considerable risk, alternative therapeutic approaches such as antifungal peptides are urgently needed. In clinical wound care, a significant focus has been directed toward novel surgical (wound) dressings as first defense lines against C. auris. Inspired by Cerberus the Greek mythological "hound of Hades" that prevents the living from entering and the dead from leaving hell, the preparation of a gatekeeper hybrid hydrogel is reported featuring lectin-mediated high-affinity immobilization of C. auris cells from a collagen gel as a model substratum in combination with a release of an antifungal peptide drug to kill the trapped cells. The vision is an efficient and safe two-layer medical composite hydrogel for the treatment of severe wound infections that typically occur in hospitals. Providing this new armament to the repertoire of possibilities for wound care in critical (intensive care) units may open new routes to shield and defend patients from infections and clinical facilities from spreading and invasion of C. auris and probably other fungal pathogens.Entities:
Keywords: Candida auris; compound encapsulation; drug delivery; intrinsic antimicrobial activity; multicomponent hydrogels
Mesh:
Substances:
Year: 2020 PMID: 32104975 DOI: 10.1002/mabi.202000005
Source DB: PubMed Journal: Macromol Biosci ISSN: 1616-5187 Impact factor: 4.979